Early Palliative Care Intervention in Malignant Glioma
Completed · Not applicable
Conditions studied: Malignant Glioma
In brief
The purpose of this research study is to determine the feasibility and acceptability of incorporating palliative care into the clinical care plans of patients newly diagnosed with malignant brain tumors. Palliative Care is a field of medicine that focuses on providing relief from symptoms and stress related to serious illnesses. This study will assess the feasibility of conducting a future study, and will gather data upon which to appropriately tailor the intervention and the future study design. The statistical analysis of this study will describe 8 components that encompass each of the 4 areas of focus or "domains": acceptability, demand, implementation, and integration.
Key facts
- Study ID
- NCT03471546
- Run by
- Duke University
- People needed
- 12
- Starts
- 2018-05-16
- Expected to finish
- 2019-06-17
- Last updated by the study team
- 2020-11-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥ 18 years of age
- Patient must have histologically confirmed, newly diagnosed WHO grade IV malignant glioma (confirmation from biopsy, sub-total, or gross-total resection)
- Tumor must be de novo grade IV malignant glioma (i.e. NOT transformed from a lower grade)
- Patient should be planning to receive standard chemoradiation (3 or 6 week protocols are acceptable)
- Treating neuro-oncologist agrees to the patient's participation in this clinical trial
- Patient should be able to read and write English
You may not qualify if…
- Patient who currently has a PC provider and/or is receiving hospice care or plans on initiating hospice at the time of enrollment
Where it is running
- The Preston Robert Tisch Brain Tumor Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.